Alsaid-Habia Talya, McLeish Alison C, Kraemer Kristen M
Department of Psychology, University of Cincinnati, Cincinnati, OH, USA.
Department of Psychological and Brain Sciences, University of Louisville, Louisville, KY, USA.
J Asthma. 2019 Oct;56(10):1120-1127. doi: 10.1080/02770903.2018.1520862. Epub 2018 Oct 4.
: Given the robust associations between anxiety and asthma, the purpose of the current study was to explore associations between asthma outcomes and tolerance for negative affective states (i.e. distress tolerance) as well as tolerance for the specific negative emotional states of anxiety and fear. : Participants were 61 nonsmoking adults with asthma (61.9% female, 54.8% African-American, = 34.72, = 13.58) who underwent spirometry and completed self-report measures. : After controlling for the effects of age, race and the physical concerns domain of anxiety sensitivity, poorer global distress tolerance and tolerance for fear and anxiety each significantly predicted poorer lung function (8.7-13.8% variance), asthma control (4.9-8.8% variance) and asthma-related quality of life (6.7-8.9%). : These findings suggest that targeting distress tolerance, specifically tolerance of fear and anxiety, may be helpful in improving asthma outcomes.
鉴于焦虑与哮喘之间存在紧密关联，本研究旨在探讨哮喘预后与对负面情绪状态的耐受性（即痛苦耐受性）以及对焦虑和恐惧等特定负面情绪状态的耐受性之间的关联。研究参与者为61名患有哮喘的非吸烟成年人（女性占61.9%，非裔美国人占54.8%，平均年龄 = 34.72岁，标准差 = 13.58），他们接受了肺活量测定并完成了自我报告测量。在控制了年龄、种族以及焦虑敏感性的身体担忧领域的影响后，较差的总体痛苦耐受性以及对恐惧和焦虑的耐受性均显著预测了较差的肺功能（方差为8.7 - 13.8%）、哮喘控制情况（方差为4.9 - 8.8%）和哮喘相关生活质量（方差为6.7 - 8.9%）。这些发现表明，针对痛苦耐受性，特别是对恐惧和焦虑的耐受性进行干预，可能有助于改善哮喘预后。
